FASN and cancer: Novel effects of OLR1on lipid metabolism could account for much of its reported pro-oncogenic activity.For example, the expression level of FASN positively correlateswith poor cancer prognosis [26], its genomic amplification is a common occurrence in somecancers [27], andits over-expression promotes transformation of epithelial cells [28].